Literature DB >> 24574209

Adverse pregnancy outcomes and risk of subsequent rheumatoid arthritis.

Kimberly K Ma1, J Lee Nelson, Katherine A Guthrie, Carin E Dugowson, Hilary S Gammill.   

Abstract

OBJECTIVE: Pregnancy and reproductive outcomes have been associated with altered risk of some autoimmune diseases, including rheumatoid arthritis (RA). We sought to determine whether prior pregnancy resulting in a low birth weight (LBW) infant or preterm birth is associated with a risk of subsequent RA in the mother.
METHODS: We conducted an analysis of RA risk in parous women from a population-based prospective study of newly diagnosed cases of RA and age-matched healthy controls. The primary outcome measure was disease status (RA versus control), with exposures of prior preterm birth and prior delivery of an infant with LBW (≤2,500 gm), very low birth weight (VLBW; ≤1,500 gm), or extremely low birth weight (ELBW; ≤1,000 gm). A preplanned analysis including only rheumatoid factor (RF)-positive RA cases was also conducted.
RESULTS: A total of 202 RA cases and 1,102 controls were analyzed. Prior delivery of an infant with ELBW was associated with RA in the mother (relative risk [RR] 3.7 [95% confidence interval (95% CI) 1.0-13.2]). Prior VLBW (RR 4.0 [95% CI 1.3-11.4]) and ELBW (RR 5.5 [95% CI 1.4-22.5]) infants were associated with RF-positive RA. Prior LBW deliveries and preterm births were more common among RA cases than controls, but the differences were not statistically significant.
CONCLUSION: Compared to those with uncomplicated pregnancies, women with a prior VLBW or ELBW delivery had a higher risk of RA, particularly RF-positive RA. This association may reflect common risk factors for pregnancy complications and RA. Alternatively, complicated pregnancy itself may confer risk of subsequent RA.
Copyright © 2014 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2014        PMID: 24574209      PMCID: PMC5318164          DOI: 10.1002/art.38247

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  31 in total

1.  Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia.

Authors:  X Y Zhong; H Laivuori; J C Livingston; O Ylikorkala; B M Sibai; W Holzgreve; S Hahn
Journal:  Am J Obstet Gynecol       Date:  2001-02       Impact factor: 8.661

2.  Pregnancy and delivery in women with chronic inflammatory arthritides with a specific focus on first birth.

Authors:  Marianne Wallenius; Johan F Skomsvoll; Lorentz M Irgens; Kjell Å Salvesen; Bjorn Y Nordvåg; Wenche Koldingsnes; Knut Mikkelsen; Cecilie Kaufmann; Tore K Kvien
Journal:  Arthritis Rheum       Date:  2011-06

3.  Maternal microchimerism in healthy adults in lymphocytes, monocyte/macrophages and NK cells.

Authors:  Laurence S Loubière; Nathalie C Lambert; Laura J Flinn; Timothy D Erickson; Zhen Yan; Katherine A Guthrie; Kathy T Vickers; J Lee Nelson
Journal:  Lab Invest       Date:  2006-09-11       Impact factor: 5.662

4.  Maternal plasma fetal DNA as a marker for preterm labour.

Authors:  T N Leung; J Zhang; T K Lau; N M Hjelm; Y M Lo
Journal:  Lancet       Date:  1998-12-12       Impact factor: 79.321

5.  Rheumatoid arthritis and pregnancy: beyond smaller and preterm babies.

Authors:  Eliza F Chakravarty
Journal:  Arthritis Rheum       Date:  2011-06

6.  Parity and HLA alleles in risk of rheumatoid arthritis.

Authors:  Katherine A Guthrie; Hilary S Gammill; Margaret M Madeleine; Carin E Dugowson; J Lee Nelson
Journal:  Chimerism       Date:  2011-01

7.  Does pregnancy provide vaccine-like protection against rheumatoid arthritis?

Authors:  Katherine A Guthrie; Carin E Dugowson; Lynda F Voigt; Thomas D Koepsell; J Lee Nelson
Journal:  Arthritis Rheum       Date:  2010-07

Review 8.  Multiple adverse pregnancy outcomes before symptom onset are associated with a worse disease outcome in women with recent-onset inflammatory polyarthritis.

Authors:  E M Camacho; S M M Verstappen; M Lunt; D K Bunn; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2011-10-13       Impact factor: 19.103

9.  Male DNA in female donor apheresis and CD34-enriched products.

Authors:  Kristina M Adams; Nathalie C Lambert; Shelly Heimfeld; Tracy S Tylee; Jennifer M Pang; Timothy D Erickson; J Lee Nelson
Journal:  Blood       Date:  2003-07-17       Impact factor: 22.113

10.  Transfer of the shared epitope through microchimerism in women with rheumatoid arthritis.

Authors:  J M Rak; L Maestroni; N Balandraud; S Guis; H Boudinet; M C Guzian; Z Yan; D Azzouz; I Auger; C Roudier; M Martin; R Didelot; J Roudier; N C Lambert
Journal:  Arthritis Rheum       Date:  2009-01
View more
  5 in total

1.  The impact of unrecognized autoimmune rheumatic diseases on the incidence of preeclampsia and fetal growth restriction: a longitudinal cohort study.

Authors:  Arsenio Spinillo; Fausta Beneventi; Elena Locatelli; Vèronique Ramoni; Roberto Caporali; Claudia Alpini; Giulia Albonico; Chiara Cavagnoli; Carlomaurizio Montecucco
Journal:  BMC Pregnancy Childbirth       Date:  2016-10-18       Impact factor: 3.007

Review 2.  The role of the prolactin/vasoinhibin axis in rheumatoid arthritis: an integrative overview.

Authors:  Carmen Clapp; Norma Adán; María G Ledesma-Colunga; Mariana Solís-Gutiérrez; Jakob Triebel; Gonzalo Martínez de la Escalera
Journal:  Cell Mol Life Sci       Date:  2016-03-29       Impact factor: 9.261

3.  Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database.

Authors:  Megan E B Clowse; Angela E Scheuerle; Christina Chambers; Anita Afzali; Alexa B Kimball; John J Cush; Maureen Cooney; Laura Shaughnessy; Mark Vanderkelen; Frauke Förger
Journal:  Arthritis Rheumatol       Date:  2018-07-22       Impact factor: 10.995

Review 4.  Feto-Maternal Microchimerism: The Pre-eclampsia Conundrum.

Authors:  Sinuhe Hahn; Paul Hasler; Lenka Vokalova; Shane Vontelin van Breda; Nandor Gabor Than; Irene Mathilde Hoesli; Olav Lapaire; Simona W Rossi
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

5.  Impact of autoimmune rheumatic diseases on birth outcomes: a population-based study.

Authors:  Jennifer Strouse; Brittney M Donovan; Munazza Fatima; Ruth Fernandez-Ruiz; Rebecca J Baer; Nichole Nidey; Chelsey Forbess; Gretchen Bandoli; Randi Paynter; Nisha Parikh; Laura Jeliffe-Pawlowski; Kelli K Ryckman; Namrata Singh
Journal:  RMD Open       Date:  2019-04-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.